Omeprazole
NDC 55111-645, Omeprazole, capsule, delayed release, from Dr. Reddy's Laboratories Limited.
- Product NDC
- 55111-645
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078490
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55111-645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE40 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55111-645-01 | 55111064501 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-645-01) |
| 55111-645-05 | 55111064505 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-645-05) |
| 55111-645-10 | 55111064510 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-645-10) |
| 55111-645-30 | 55111064530 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-645-30) |
| 55111-645-34 | 55111064534 | 12 BOTTLE in 1 CARTON (55111-645-34) / 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
| 55111-645-78 | 55111064578 | 10 BLISTER PACK in 1 CARTON (55111-645-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (55111-645-79) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/603d2d06-c5e8-4378-a422-8dca1a410af7NADAC price for package 55111064501
GET /v1/drugs/nadac/55111064501NADAC price for package 55111064505
GET /v1/drugs/nadac/55111064505NADAC price for package 55111064510
GET /v1/drugs/nadac/55111064510NADAC price for package 55111064530
GET /v1/drugs/nadac/55111064530NADAC price for package 55111064534
GET /v1/drugs/nadac/55111064534
Use it
Look up 55111-645 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55111-645 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55111-645. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.